Literature DB >> 10219758

Epitope mapping of Aleutian mink disease parvovirus virion protein VP1 and 2.

F Costello1, N Steenfos, K T Jensen, J Christensen, E Gottschalck, A Holm, B Aasted.   

Abstract

Six overlapping fragments of the Aleutian Mink Disease parvoVirus (AMDV) virion protein VP1 and 2 (VP1/2) gene were inserted into the expression vector pMAL-c2. Four of the clones carried large overlapping fragments covering the entire VP1/2 gene. The remaining two clones covered specifically chosen regions within the VP1/2 gene. Using a Western blotting detection system, sera from AMDV-infected mink were tested against the recombinant polypeptides. These studies showed reactions primarily directed against the two AMDV polypeptides ranging from amino acids 297 to 518. Weaker reactions against other regions of the VP1/2 were also observed. The small fusion protein designed to cover the presumed AMDV VP1/2 loop 4 was purified by affinity chromatography and used to develop solid-phase immunoassays. Twelve small synthetic peptides were constructed and used as inhibitors. A peptide covering amino acids S428 to T448 was shown to block the reactivity of a pool of positive mink sera, indicating the presence of one dominant linear epitope.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219758     DOI: 10.1046/j.1365-3083.1999.00499.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  A comparative molecular characterization of AMDV strains isolated from cases of clinical and subclinical infection.

Authors:  Marek Kowalczyk; Andrzej Jakubczak; Beata Horecka; Krzysztof Kostro
Journal:  Virus Genes       Date:  2018-05-29       Impact factor: 2.332

2.  Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production.

Authors:  Huang-Ge Zhang; Jinfu Xie; Igor Dmitriev; Elena Kashentseva; David T Curiel; Hui-Chen Hsu; John D Mountz
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

4.  A new perspective on the evolution and diversity of the genus Amdoparvovirus (family Parvoviridae) through genetic characterization, structural homology modeling, and phylogenetics.

Authors:  Marta Canuti; Judit J Pénzes; Andrew S Lang
Journal:  Virus Evol       Date:  2022-06-17

5.  Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation.

Authors:  M E Bloom; S M Best; S F Hayes; R D Wells; J B Wolfinbarger; R McKenna; M Agbandje-McKenna
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system.

Authors:  Jesper Christensen; Peter Tattersall
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Genetic characterization of the complete genome of an Aleutian mink disease virus isolated in north China.

Authors:  Ji Xi; Jigui Wang; Yongle Yu; Xiaomei Zhang; Yaping Mao; Qiang Hou; Weiquan Liu
Journal:  Virus Genes       Date:  2016-03-23       Impact factor: 2.332

8.  Development of a Peptide ELISA for the Diagnosis of Aleutian Mink Disease.

Authors:  Fanshu Ma; Lei Zhang; Yang Wang; Rongguang Lu; Bo Hu; Shuang Lv; Xianghong Xue; Xintong Li; Mingyu Ling; Sining Fan; Hailing Zhang; Xijun Yan
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

9.  Breeding parameters on a mink farm infected with Aleutian mink disease virus following the use of methisoprinol.

Authors:  Marek Kowalczyk; Bolesław Gąsiorek; Krzysztof Kostro; Ewa Borzym; Andrzej Jakubczak
Journal:  Arch Virol       Date:  2019-08-19       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.